Nucleate is a nonprofit organization that was started to empower the next generation of biotech leaders. Together with BLUE KNIGHT™, we are excited to share the story of Glyphic Biotechnologies, a protein sequencing company that originated in academia. Tell us more about Glyphic Biotechnologies and the impact you hope to make on patients and the community? Although decoding the human genome through the invention of DNA sequencing has…

Nucleate, the nonprofit organization led by academic trainees and dedicated to empowering future biotech leaders, today announced the renewal of its partnership with Alnylam Pharmaceuticals. Entrepreneurs entering the biotech industry can find it tough to break into, limiting innovation in disease treatment. Nucleate aims to solve this problem by providing…

Nucleate, the nonprofit organization dedicated to empowering the next generation of biotech leaders, announced today the planned co-President transition of Oliver Dodd to Michael Retchin in June 2023. This transition marks a significant milestone for Nucleate as a student-led organization, concluding the first period of co-Presidency transition. Oliver joined Nucleate…

Nucleate, the nonprofit organization dedicated to empowering future biotech leaders, announced 143 venture teams in the first international cycle of its Activator program. Meet the 2023 Activator teams: teams.nucleate.xyz. Participating teams will now refine their scientific discoveries into biotech venture theses and train under Nucleate’s unparalleled network, rigorous curriculum, funded…

Nucleate Boston, a nonprofit organization dedicated to empowering the next generation of biotech leaders, announces its partnership with Mintz, a leading law firm in the biotechnology sphere. Mintz will provide exclusive legal support to Nucleate Boston’s 2023 Activator program, which facilitates early-stage company formation in the life sciences. As noted…

Nucleate, the nonprofit organization dedicated to empowering tomorrow’s biotech leaders by educating today’s academic trainees, announced today the planned co-President transition of Soufiane Aboulhouda to Samantha Sison at the end of June 2023. This transition marks a significant milestone for Nucleate as a student-led organization, and represents the first transition…

Novo Nordisk to bolster their support to Nucleate by renewing their sponsorship of Nucleate Boston’s Activator Program and extend it to Seattle chapter, facilitating formation of early-stage life science ventures. Today, the Nucleate Boston chapter is pleased to announce renewal of its partnership with Novo Nordisk which will be anchored…

Nucleate, the non-profit organization led by academic trainees and dedicated to empowering future biotech leaders, today announced that the venture capital firm BlueYard will become a Platinum Level Sponsor of the 2023 Activator Program. The partnership enables Nucleate to award BlueYard Venture Funding Prizes totalling $2M to 10–20 recipients from…

Nucleate, a nonprofit organization led by academic trainees and dedicated to empowering future biotech leaders, today announced that Eli Lilly and Company (NYSE: LLY) will become a Platinum Level Sponsor of the 2023 Activator Program. Nucleate’s equity-free Activator program has supported more than 100 venture teams in their earliest stages…